1-3 of 3
Kazuhito Naka, Ph.D.
Close
Sort by
Journal Articles

mTORC1 Inactivation Prevents and Eradicates Acute Lymphoblastic T-Cell Leukemia

Takayuki Hoshii, Ph.D., Atsuo Kasada, MD, Tomoki Hatakeyama, Masashi Ohtani, Ph.D., Yuko Tadokoro, Ph.D., Kazuhito Naka, Ph.D., Tsuneo Ikenoue, MD., Ph.D., Tomokatsu Ikawa, Ph.D., Hiroshi Kawamoto, MD., Ph.D., Kimi Araki, Ph.D., Ken-ichi Yamamura, MD., Ph.D., Atsushi Iwama, MD., Ph.D., Satoshi Matsuda, MD., Ph.D., Atsushi Hirao, MD., Ph.D.
Journal: Blood
Blood (2013) 122 (21): 1211.
https://doi.org/10.1182/blood.V122.21.1211.1211
Published: 2013
Journal Articles

Molecular Mechanism Regulating Foxo In Leukemia Initiating Cells of Chronic Myeloid Leukemia.

Kazuhito Naka, Ph.D., Takayuki Hoshii, Ph.D., Yuko Tadokoro, Ph.D., Takako Ooshio, Ph.D., Yukio Kondo, M.D.Ph.D., Shinji Nakao, MD, PhD, Noboru Motoyama, Ph.D., Atsushi Hirao, M.D.Ph.D.
Journal: Blood
Blood (2010) 116 (21): 3391.
https://doi.org/10.1182/blood.V116.21.3391.3391
Published: 2010
Journal Articles

Foxo3a Is Essential for the Quiescence and Self-Renewal of Hematopoietic Stem Cells.

Kana Miyamoto, MD, Atsushi Hirao, M.D., Ph.D., Kiyomi Y. Araki, Ph.D., Fumio Arai, Ph.D., Kazuhito Naka, Ph.D., Keiyo Takubo, M.D., Sahoko Matsuoka, M.D., Ph.D., Satoshi Yamazaki, Keisuke Ito, M.D., Ph.D., Masako Ohmura, Ph.D., Kentaro Hosokawa, Mine Harada, M.D., Ph.D., Noboru Motoyama, Ph.D., Toshio Suda, M.D., Ph.D.
Journal: Blood
Blood (2006) 108 (11): 442.
https://doi.org/10.1182/blood.V108.11.442.442
Published: 2006